Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook
Published in Oncology Business Week, August 30th, 2009
The net loss allocable to common shareholders for the three months ended June 30, 2009 was $2.6 million or ($0.06) per share compared to a net loss allocable to common shareholders of $3.4 million or ($0.09) per share for the three months ended June 30, 2008. The decrease in the net loss is due to decreased costs involved in the clinical development of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- ABM Industries Incorporated
ABM Industries Hosts First Annual Charity Golf Outing to Benefit Children with Cancer - Amazon Defense Coalition
Amazon Defense Coalition: Chevron Using Deep Pockets to Manufacture "Proof" in $27 Billion Environmental Trial - American Century Investments
American Century Investments President & CEO Jonathan Thomas to Participate in LIVESTRONG(R) Global Cancer Summit in Dublin, Ireland - Antares Pharma, Inc.
Antares Pharma Welcomes Eamonn P. Hobbs to Board of Directors - Array BioPharma Inc.
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2009 - Bio-Matrix Scientific Group, Inc.
Bio-Matrix Scientific Group in Joint Venture with Therinject and Entest BioMedical for New Immuno-Therapeutic Cancer Vaccine - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
